Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Small

Showing results (351-360 of 476) with videos related to

Pageof 48
Sort By:
Journal of the American College of Cardiology|October 23, 2012
Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trialDavid Erlinge, Jurrien Ten Berg, David Foley, et al.
Journal of Graduate Medical Education|June 21, 2014
Impact of protected sleep period for internal medicine interns on overnight call on depression, burnout, and empathyJudy A Shea, Lisa M Bellini, David F Dinges, et al.
Circulation. Cardiovascular Quality and Outcomes|June 17, 2025
Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular DiseaseLouise B Russell, Kevin G M Volpp, Mitesh S Patel, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 8, 2015
Absolute bioavailability of evacetrapib in healthy subjects determined by simultaneous administration of oral evacetrapib and intravenous [(13) C8 ]-evacetrapib as a tracerEllen A Cannady, Aktham Aburub, Chris Ward, et al.
Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal diseaseD S Small, R E Wrishko, C S Ernest, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2020
Using Medicare claims in identifying Alzheimer's disease and related dementiasSiddharth Jain, Paul R Rosenbaum, Joseph G Reiter, et al.
Journal of Pediatric Hematology/Oncology|December 11, 2014
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging studyLori Styles, Darell Heiselman, Lori E Heath, et al.
JAMA Network Open|April 1, 2020
Effect of Default Options in Advance Directives on Hospital-Free Days and Care Choices Among Seriously Ill Patients: A Randomized Clinical TrialScott D Halpern, Dylan S Small, Andrea B Troxel, et al.
The New England Journal of Medicine|May 22, 2013
A randomized trial of nighttime physician staffing in an intensive care unitMeeta Prasad Kerlin, Dylan S Small, Elizabeth Cooney, et al.
International Journal of Obesity (2005)|March 16, 2017
Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profilingT Pallister, M A Jackson, T C Martin, et al.
Pageof 48

Showing results (351-360 of 476) with videos related to

Sort By:
Pageof 48
Journal of the American College of Cardiology|October 23, 2012
Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trialDavid Erlinge, Jurrien Ten Berg, David Foley, et al.
Journal of Graduate Medical Education|June 21, 2014
Impact of protected sleep period for internal medicine interns on overnight call on depression, burnout, and empathyJudy A Shea, Lisa M Bellini, David F Dinges, et al.
Circulation. Cardiovascular Quality and Outcomes|June 17, 2025
Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular DiseaseLouise B Russell, Kevin G M Volpp, Mitesh S Patel, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 8, 2015
Absolute bioavailability of evacetrapib in healthy subjects determined by simultaneous administration of oral evacetrapib and intravenous [(13) C8 ]-evacetrapib as a tracerEllen A Cannady, Aktham Aburub, Chris Ward, et al.
Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal diseaseD S Small, R E Wrishko, C S Ernest, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2020
Using Medicare claims in identifying Alzheimer's disease and related dementiasSiddharth Jain, Paul R Rosenbaum, Joseph G Reiter, et al.
Journal of Pediatric Hematology/Oncology|December 11, 2014
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging studyLori Styles, Darell Heiselman, Lori E Heath, et al.
JAMA Network Open|April 1, 2020
Effect of Default Options in Advance Directives on Hospital-Free Days and Care Choices Among Seriously Ill Patients: A Randomized Clinical TrialScott D Halpern, Dylan S Small, Andrea B Troxel, et al.
The New England Journal of Medicine|May 22, 2013
A randomized trial of nighttime physician staffing in an intensive care unitMeeta Prasad Kerlin, Dylan S Small, Elizabeth Cooney, et al.
International Journal of Obesity (2005)|March 16, 2017
Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profilingT Pallister, M A Jackson, T C Martin, et al.
Pageof 48